60 Degrees Pharmaceuticals, Inc. - Bathi saben siji saham sajrone 12 wulan pungkasan SXTP

60 Degrees Pharmaceuticals (SXTP) relies on US government defense contracts that ensure a stable cash flow, although the development of antimalarial drugs requires significant R&D expenditures without economies of scale. This chart of EPS YoY TTM in the GURU.Markets terminal illustrates the trend, where 86.00 represents the current level of the metric. Supply and trial efficiency is achieved through extensive outsourcing of international logistics and manufacturing.
60 Degrees Pharmaceuticals Inc. - rincian analitis lan metrik utama (SXTP)

The market views 60 Degrees Pharmaceuticals (SXTP) as a promising asset with high capitalization potential. This indicator measures the annual change in earnings per share over a rolling period, neutralizing seasonal fluctuations and one-off spikes. By analyzing the EPS YoY TTM growth trajectory, an investor can see the actual effectiveness of the company's monetization of its monopoly position in the antimalarial niche. The growth of this metric confirms the business's ability to exercise pricing power over the military and tourism segments. The asset belongs to the high-risk biotechnology company class.